HIGHLIGHTS
- who: from the (UNIVERSITY) have published the research: Genetically diverse mouse platform to xenograft cancer cells, in the Journal: (JOURNAL) of 10/01/2022
- what: This led to the National Institutes of Health (NIH), in June 2021, to cite a lack of genetic diversity in preclinical studies as one of the main reasons for failure of clinical trials (ACD Working Group on Enhancing Rigor, Transparency, and Translatability in Animal Research; https://acd.od.nih.gov/documents/presentations/ 06112021_RR-AR%20Report.pdf ). The authors show, using the panel of three to five host strains, that the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.